Large Volume Parenteral (LVP) Market Report Examines Leading Companies And Growth Opportunities

The global healthcare sector is rapidly evolving, with intravenous therapies becoming increasingly vital for patient care. Among these, the large volume parenteral (LVP) market is gaining significant traction, driven by medical advancements and growing patient needs. Below, we explore the current market outlook, key players, emerging trends, and detailed segment analyses shaping the future of the LVP industry.

Projected Growth and Value of the Large Volume Parenteral Market by 2030
The large volume parenteral market is set to experience considerable expansion over the next several years. Forecasts indicate that the market will reach a valuation of $21.37 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.7%. This upward trajectory is fueled by several factors, including an aging global population, the increasing incidence of chronic illnesses, heightened demand for parenteral nutrition, and the ongoing development of healthcare infrastructure in emerging economies. Additionally, growth in emergency and trauma care services contributes significantly to this positive outlook. Key trends expected to influence the market include a shift toward non-PVC and environmentally friendly LVP packaging, a surge in ready-to-use and premixed infusion solutions, a growing emphasis on sterility and contamination prevention, increased application in critical care and emergency settings, and a rise in hospital-based infusion therapy volumes.

The large volume parenteral (lvp) market size has grown strongly in recent years. It will grow from $13.53 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising hospitalization rates, growth in intravenous fluid therapy usage, increasing surgical procedures, expansion of critical care infrastructure, growth in infectious disease treatment.

Download a free sample of the large volume parenteral (lvp) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Drivers Boosting the Large Volume Parenteral Market's Expansion
One of the primary factors propelling the LVP market is the global rise in chronic disease cases, which necessitates long-term and complex intravenous therapies. Coupled with this is the expansion of healthcare facilities, particularly in emerging markets where improving access and infrastructure are making advanced medical treatments more readily available.
Alongside these, increasing awareness and acceptance of parenteral nutrition play a pivotal role in market growth. Patients who are unable to take nutrition orally are relying more on intravenous solutions, which is driving demand for LVP products. Furthermore, the rise of emergency and trauma care services worldwide is expanding the need for large volume infusion solutions in critical care environments.

Leading Industry Players Driving the LVP Market Forward
The large volume parenteral market is dominated by several prominent companies known for their innovation and extensive product portfolios. Key players include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, and Grifols S.A. Other significant contributors include Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, and Akums Drugs & Pharmaceuticals Ltd. This diverse group also features companies like Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., and Higgs Healthcare.

View the full large volume parenteral (lvp) market report:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations Leading the Way in the Large Volume Parenteral Market
Companies in the LVP sector are increasingly focused on developing advanced smart infusion devices to improve safety and efficiency in intravenous therapy. These innovations include intelligent large-volume infusion pumps that combine automation, connectivity, and dose-error reduction technologies to enhance treatment accuracy and patient safety.
For example, in April 2024, Baxter International Inc. secured U.S. FDA approval for its Novum IQ Large-Volume Infusion Pump, featuring Dose IQ smart-dose software. This cutting-edge device facilitates high-rate fluid delivery with integrated drug library support to minimize dosing errors. Additionally, it offers seamless connectivity with hospital electronic medical records and monitoring systems, streamlining workflows and reducing the chances of medication mistakes in busy clinical environments.

In-Depth Breakdown of the Large Volume Parenteral Market Segments
The large volume parenteral market can be categorized into several key segments to better understand its composition and opportunities. These include:
1) Type: Soft Bag LVP, Plastic Bag LVP, and Glass Bottle LVP.
2) Volume: 100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, and volumes exceeding 2000 ML.
3) Application: Basic Infusion, Therapeutic Infusion, and Nutritional Infusion.
4) End-User: Hospitals, Medical Centers, and Other End Users.
Further subcategories delve into materials and packaging details such as PVC and Non-PVC soft bags under the Soft Bag LVP category; polypropylene and polyethylene bags within Plastic Bag LVPs; and single-use versus multi-dose glass bottles under the Glass Bottle LVP segment. This segmentation provides a comprehensive view of the market landscape and highlights areas for targeted growth and innovation.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.